Recent advancements in stem cell technology open a new door for patients suffering from
diseases and disorders that have yet to be treated. Stem cell-based therapy, including …

Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment
of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from …

Background Adipose-derived stem cells (ASCs) have been introduced as an alternative to
bone marrow mesenchymal stem cells (BMSCs) for cell-based therapy. However, different …

Identified 50 years ago, mesenchymal stromal/stem cells (MSCs) immediately generated a
substantial interest among the scientific community because of their differentiation plasticity …

Following their discovery over 50 years ago, mesenchymal stromal cells (MSCs) have
become one of the most studied cellular therapeutic products by both academia and industry …

As one of the problems and diseases for women before 40 years, premature ovarian failure
(POF) could be characterized by amenorrhea, low estrogen levels, infertility, high …

The bone regeneration efficiency of bone marrow mesenchymal stem cells (BMSCs) and
dental pulp mesenchymal stem cells (DPSCs) combined with xenografts in the craniofacial …

Endometriosis is an estrogen-dependent inflammatory disease that affects up to 10% of
women of reproductive age and accounts for up to 50% of female infertility cases. It has …

MSCs products as well as their derived extracellular vesicles, are currently being explored
as advanced biologics in cell-based therapies with high expectations for their clinical use in …

Effective bone regeneration through tissue engineering requires a combination of
osteogenic progenitors, osteoinductive biofactors and biocompatible scaffold materials …